Acute Pulmonary Thromboembolism: A Retrospective Study in a Nigerian Private Tertiary Hospital

  • JO Ogunkoya
  • AO Oluwole
  • BO Adefuye
  • AO Adebola-Yusuf
  • O Ehioghae
Keywords: Anticoagulants, Computerized Tomography Pulmonary Angiography, Intensive Care Unit, Pulmonary Embolism, Venous Thromboembolism


Background: Pulmonary embolism (PE) is a disease associated with high morbidity and mortality in the more technically advanced western world. However, in Africa and Nigeria in particular, the burden of PE is largely poorly defined as few data are available.

Objectives: To characterize the clinical profile, management and outcomes in PE patients confirmed with Computerized Tomography Pulmonary Angiography (CTPA).

Methods: A retrospective study was conducted at Babcock University Teaching Hospital, Ilishan-Remo, Nigeria. The medical records of PE patients confirmed by CTPA and admitted to the intensive care unit of the hospital spanning July 2016 to June 2020 were retrieved for analysis.

Results: Thirty-one patients with the age range of 26 to 93 years were included and the mean age was 55.5±18.5 years. Breathlessness was the most prevalent presenting symptom. In the majority of patients (48.4%), the risk factors were not known. However, the most common risk factor and co-morbidity was pregnancy (16.1%). The in-hospital mortality rate was 9.7%.

Conclusion: The clinical characteristics of PE in this cohort were similar to those described in the literature. The high mortality rate in this study also underscores the need for large population studies in black Africans.


Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014; 34: 2363–2371.

Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016; 118: 1340–1347.

Keller K, Hobohm L, Ebner M, Kresoja KP, Munzel T, Konstantinidis SV, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germans. Eur Heart J 2020; 41: 522-529.

ISTH Steering Committee for World Thrombosis. Thrombosis: a major contributor to global disease burden. J Thromb Haemost 2014; 12: 1580–90.

Galson SK. The surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism. Available at: http://www.surgeongeneral. gov/topics/deepvein/. Accessed 19 April 2010.

Deitelzweig SB, Lin J, Johnson BH, Schulman KL. Venous thromboembolism in the US: does race matter? J Thromb thrombolysis 2011; 31: 133-138.

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756–764.

Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12: 464–474.

Lambrini K, Konstantinos K, Christos I, Petros O, Areti T. Pulmonary Embolism: A Literature Review. Am J Nurs Sci 2018; 7: 57-61.

Kapetaniou A. Pulmonary embolism-Diagnosis and treatment. Medical Analects 2011; 9: 390-394.

Doğan H, de Roos A, Geleijins J, Huisman MV, Kroft LJ. The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism. Diagn Interv Radiol 2015; 21: 307–316.

White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93:298–305.

Mbatchou Ngahane BH, Kamdem F, Njonnou SRS, Chebou N, Dzudie A, Ebongue SA, et al. Epidemiology, clinical and paraclinical presentations of pulmonary embolism: A cross-sectional study in a sub-Saharan Africa setting. Open J Respir Dis 2019; 9: 89-99.

Awotedu AA, Igbokwe EO, Ekang EE, Aghadiuno PO. Pulmonary embolism in Ibadan, Nigeria: five years autopsy report. Cent Afr J Med 1992; 38:432-435.

Manuel A, Aufico A, Africano R, Peralta T, Salas A, Silva A, et al. Clinical profile, management and outcomes of patients with pulmonary embolism: a retrospective tertiary centre study in Angola. Cardiovasc J Afr 2017; 28: 356-361.

Igun GO. A 10-year review of venous thromboembolism in surgical patients seen in Jos, Nigeria. Niger Postgrad Med J 2001; 8: 69–73.

Tambe J, Moifo B, Fongang E, Guegang E, Juimo AG. Acute pulmonary embolism in the era of multidetector CT: a reality in sub-Saharan Africa. BMC Med Imaging 2012; 12: 31.

Danwang C, Temgoua MN, Agbor VN, Tankeu AT, Noubiap JJ. Epidemiology of venous thromboembolism in Africa: a systematic review. J Thromb Haemost 2017; 15: 1770–1781.

Pollack CV, Schreiber D, Goldhaber SZ, Slattery D, Fanikos J, O’Neil BJ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol 2011; 57: 700–706.

Eng J, Krishnan JA, Segal JB, Bolger DT, Tamariz LJ, Streiff MB, et al. Accuracy of CT in the Diagnosis of Pulmonary Embolism: A Systematic Literature Review. Am J Roentgenol 2004; 183: 1819-1827.

Vamsidhar A, Rajasekhar D, Vanajakshamma V, Lakshmi AY, Latheef K, Siva Sankara C, et al. Comparison of PESI, Echocardiogram, CTPA and NT-ProBNP as risk stratification tools in patients with acute pulmonary embolism. Indian Heart J 2017; 69: 68-74.

Nakamura M1, Fujioka H, Yamada N, Sakuma M, Okada O, Nakanishi N, et al. Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 2001; 24: 132–138.

International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM). Available at: Accessed March 2021.

Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386–1389.

Volschan A, Albuquerque DC, Tura BR, Knibel Mde F, Souza PC, Toscano ML. Pulmonary embolism: multicenter registry in tertiary hospitals. Rev Bras Ter Intensiva 2009; 21: 237–246.

Goldhaber SZ. Deep venous thrombosis and pulmonary thromboembolism. In: Kasper D, Hauser S, Jameson JL, Fauci A, Longo DL, Loscalzo JL (Eds). Harrison’s Principles of Internal Medicine. 19th Edition. London: McGraw-Hill, 2015: p.1631–1637.

Danielsbacka JS, Hanssonc PO, Mannerkorpi K, Olsén MF. Physical activity and respiratory symptoms after pulmonary embolism. A longitudinal observational study. Thrombosis Res 2020; 189: 55–60.

Penaloza A, Kline J, Verschuren F, Courtney DM, Zech F, Derrien B, et al. European and American suspected and confirmed pulmonary embolism populations: comparison and analysis. J Thrombosis Haemostasis 2012; 10: 375–381.

Ibrahim SA, Stone RA, Obrosky S, Sartorius J, Fine MJ, Aujesky D. Racial Differences in 30-Day Mortality for Pulmonary Embolism. Am J Public Health 2006; 96: 2161-2164.

Mousa AY, Broce M, De Wit D, Baskharoun M, Abu-Halimah S, Yacoub M, et al. Appropriate use of venous imaging and analysis of the D-Dimer/ Clinical Probability Testing Paradigm in the diagnosis and location of deep venous thrombosis. Ann Vasc Surg 2018; 50: 21-29.

Mousa AY, Broce M, Gill G, Kali M, Yacoub M, AbuRahma AF. Appropriate use of D-Dimer Testing can minimize overutilization of Venous Duplex Ultrasound in a contemporary High-Volume Hospital. Ann Vasc Surg 2015; 29: 311-317.

Original Research